The Theophylline Extended-Release Ta, cataloged under National Stock Number 6505-01-159-9250, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bristol-Myers Squibb Co Westwood-Squibb Pharmaceuticals Div. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-159-9250 |
| Primary Part Number | NDC00087-0519-41 |
| Item Name | Theophylline Extended-Release Ta |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bristol-Myers Squibb Co Westwood-Squibb Pharmaceuticals Div |
| Status | ACTIVE |
| Therapeutic Equivalent | QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL |
| Primary Container Content Quantity | 100.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00087-0519-41 | Bristol-Myers Squibb Co Westwood-Squibb Pharmaceuticals Div (USA) |
| Reference | Meaning |
|---|---|
| NDC61570-0019-01 | 3/9 Design control — primary reference Monarch Pharmaceuticals Inc |
| QUIBRON-T/SR | 5/1 Secondary reference Mead Johnson & Company, Llc |
NSN 6505-01-159-9250 is a Theophylline Extended-Release Ta, manufactured by Bristol-Myers Squibb Co Westwood-Squibb Pharmaceuticals Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-159-9250 has 1 manufacturer part number on file: NDC00087-0519-41 (Bristol-Myers Squibb Co Westwood-Squibb Pharmaceuticals Div).
Key specifications for NDC00087-0519-41: Therapeutic Equivalent: QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL; Primary Container Content Quantity: 100.000 TABLETS; Primary Container Type: BOTTLE; Special Features: ANHYDROUS. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.